Target intelligence / Profile preview

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (NDUFA1)

Target
NDUFA1
Molecular classification
Enzyme, Mitochondrial complex I subunit, Accessory protein
01

Overview

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (NDUFA1) is a small accessory subunit of mitochondrial complex I, located within the inner mitochondrial membrane. While not directly involved in catalysis, it facilitates complex assembly, stabilizes structural organization, helps anchor complex I, and contributes indirectly to proton translocation during electron transfer from NADH to ubiquinone. Dysfunction or mutation of NDUFA1 can impair ATP production, increase ROS, and is causative in rare mitochondrial disorders such as complex I deficiency and Leigh syndrome. Complex I activity and associated ROS generation are of clinical importance; numerous drugs and toxins (e.g., metformin, rotenone, paraquat) interact with complex I—sometimes targeting NDUFA1—and carry therapeutic or safety implications.

Other names
CI-MWFEComplex I-MWFENADH-ubiquinone oxidoreductase MWFE subunitMWFEMC1DN12Complex I MWFE subunitZNF183NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1NADH:ubiquinone oxidoreductase MWFE subunit
02

Mechanism of action

Inhibitors (Metformin, Rotenone): reduce electron flow through complex I, decrease ATP synthesis, increase mitochondrial ROS generation, trigger apoptosis in high doses/contexts

03

Biological functions

Electron transfer from NADH to ubiquinoneAssembly and stability of complex IMitochondrial oxidative phosphorylation/ATP synthesisRegulation of proton-motive forceMay participate in mitochondrial membrane proton translocation anchoring
04

Disease associations

Mitochondrial complex I deficiency (various nuclear types)Leigh syndromeNeurodegenerative diseases via mitochondrial dysfunctionImplicated in other disorders involving oxidative stress and apoptosis
05

Safety considerations

Off-target toxicity with complex I inhibitors (e.g., Rotenone: neurotoxicity, potential Parkinsonism)Risk of metabolic crisis due to impaired mitochondrial functionIncreased production of reactive oxygen species (ROS) leading to cell damage
06

Interacting drugs

Metformin (mild complex I inhibitor)

2 more in the full profile.

07

Biomarkers

Complex I activity (used clinically in diagnosing mitochondrial disorders)Elevated ROS levels (as marker of dysfunction)Mutational analysis (for complex I hereditary deficiencies)

Beyond the preview

Go deeper on NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (NDUFA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (NDUFA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call